This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
cancer to progress to late-stage cancer; years before late-stage CRC is detected; proportion of cancers detected in the early stage; sensitivity for polyps and CRC and specificity of FOBT; sensitivity and specificity of FS and COL; rate of colonoscopy-induced perforation of the large bowel, and COL-induced mortality. Additional to the initial model, racial and ethnic differences in colorectal cancer incidence, the proportion of left-sided cancers, and the proportion of early cancers were included.
Study designs and other criteria for inclusion in the review
The study designs of the primary studies were not reported. However two data sources were mentioned: the California Cancer Registry, and the Surveillance, Epidemiology and End Results (SEER) Cancer Incidence Public-Use Database 1973-1996.
Sources searched to identify primary studies
Not stated.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Methods of combining primary studies
Investigation of differences between primary studies
Results of the review
It was estimated that it would take 2 years for a new invasive cancer to progress to late-stage cancer.
It was estimated that it would take 2 years before late-stage CRC is detected.
The proportion of cancers detected in the early stage was estimated to be between 33% and 36%.
The sensitivity of FOBT was 10% for polyps and 60% for CRC.
The specificity of FOBT was 90%.
The sensitivity and specificity of FS/COL were 90% and 98%, respectively.
The rate of COL-induced perforation of the large bowel was 7 in 10,000.
The COL-induced mortality was 5 in 100,000.
The California Cancer Registry estimates (SEER estimates in brackets) of the proportion of Colorectal Cancers occurring before age 50 were 13 (8.6) for Asians, 10.7 (10.6) for blacks, 13.7 (11.1) for Latinos and 5.4 (5.5) for
The study discussed the cost-effectiveness of CRC screening in racial and ethnic groups, but the authors pointed out that a preliminary key issue was whether eligible Americans do undergo screening for CRC. Thus the main implication of the study was that screening should be encouraged among those patients who may receive the greatest benefits from the intervention.
